Insightful Word
  • Investing
  • Stock
  • Economy
  • Politics
  • Investing
  • Stock
  • Economy
  • Politics
No Result
View All Result
Insightful Word
No Result
View All Result
Home Stock

Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 billion

admin by admin
October 23, 2024
in Stock
0
Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 billion
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

(Reuters) – Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday.

As part of the deal, the U.S. drugmaker paid $30 million upfront. Modifi is also eligible to receive potential milestone payments of up to $1.3 billion in exchange for a new class of therapies, KL-50 — being developed against difficult-to-treat brain tumors, including glioblastomas.

New Haven, Connecticut-based Modifi is a pre-clinical stage company, which develops cancer therapies that aim to selectively kill cancer cells by modifying cancer DNA.

Modifi has raised $10.7 million to date in seed funding and is backed by investors including American Cancer Society’s investment arm, BrightEdge.

Merck has been in pursuit of eligible candidates that could potentially make up for a loss of revenue from its aging blockbuster cancer immunotherapy, Keytruda, which is set to lose its patent protection by the end of the decade.

Last year, the company struck a $5.5 billion deal with Japan’s Daiichi Sankyo to jointly develop three of its targeted cancer therapies, known as antibody drug conjugates, which work like “guided missiles” against tumor cells while sparing healthy ones.

This post appeared first on investing.com

Previous Post

Earnings call: Cadence Bank reports steady Q3 growth, eyes future momentum

Next Post

McDonald’s E. coli crisis: the bacteria has a history of taking down restaurant sales and shares

admin

admin

Next Post
McDonald’s E. coli crisis: the bacteria has a history of taking down restaurant sales and shares

McDonald’s E. coli crisis: the bacteria has a history of taking down restaurant sales and shares

Trending News

What policy outcomes are likely regardless of the US election results?

What policy outcomes are likely regardless of the US election results?

November 2, 2024
SLV ETF stock: What next for the flagship silver ETF?

SLV ETF stock: What next for the flagship silver ETF?

January 2, 2025
How Trump’s billionaire Cabinet sparks conflict-of-interest concerns

How Trump’s billionaire Cabinet sparks conflict-of-interest concerns

December 12, 2024
Subscribe to Insightful Word


    Recent News

    S&P 500 nears record high despite headwinds: key drivers behind the surprise rally

    S&P 500 nears record high despite headwinds: key drivers behind the surprise rally

    June 26, 2025
    Top Nasdaq 100 Index stocks of 2025 as it breaks new all-time high

    Top Nasdaq 100 Index stocks of 2025 as it breaks new all-time high

    June 26, 2025
    S&P 500 nears record high as Wall Street opens higher amid tech momentum

    S&P 500 nears record high as Wall Street opens higher amid tech momentum

    June 26, 2025
    Galaxy Digital launches $175 million fund to back DeFi and stablecoin startups

    Galaxy Digital launches $175 million fund to back DeFi and stablecoin startups

    June 26, 2025

    Recent News

    S&P 500 nears record high despite headwinds: key drivers behind the surprise rally

    S&P 500 nears record high despite headwinds: key drivers behind the surprise rally

    June 26, 2025
    Top Nasdaq 100 Index stocks of 2025 as it breaks new all-time high

    Top Nasdaq 100 Index stocks of 2025 as it breaks new all-time high

    June 26, 2025

    Latest News

    • S&P 500 nears record high despite headwinds: key drivers behind the surprise rally
    • Top Nasdaq 100 Index stocks of 2025 as it breaks new all-time high
    • S&P 500 nears record high as Wall Street opens higher amid tech momentum

    About Insightful Word

    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools
    • Contacts
    • Cookie Notice
    • Privacy Policy
    • Terms of Service
    • Trading tools

    Copyright © 2025 Insightfulword.com. All Rights Reserved.

    No Result
    View All Result
    • Investing
    • Stock
    • Economy
    • Politics

    Copyright © 2025 Insightfulword.com. All Rights Reserved.